Evidence map›Paper›PMID 23385588›Full record

ArticleNature communications2013

Janus graphene from asymmetric two-dimensional chemistry.

Liming Zhang, Jingwen Yu, Mingmei Yang, Qin Xie, Hailin Peng, Zhongfan Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Liquid-Phase Fabrication of Janus 2D Materials: Defect-Rich MoSSmall (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Glaphene: A Hybridization of 2D Silica Glass and Graphene.Advanced materials (Deerfield Beach, Fla.) · 2025
    Article
  9. Article
  10. Article
  11. Janus and Amphiphilic MoSSmall methods · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Molecular Stacking on Graphene.Angewandte Chemie (International ed. in English) · 2022
    Article
  18. Article
  19. Interplay between quantum anomalous Hall effect and magnetic skyrmions.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liming ZhangCenter for Nanochemistry, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.
Jingwen Yu
Mingmei Yang
Qin Xie
Hailin Peng
Zhongfan Liu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Janus materials have distinct surfaces on their opposite faces. Graphene, a two-dimensional giant molecule, provides an excellent candidate to fabricate the thinnest Janus discs and study the asymmetric chemistry of atomic-thick nanomembranes using covalent chemical functionalisation. Here we present the first experimental realisation of nonsymmetrically modified single-layer graphene--Janus graphene--which is fabricated by a two-step surface covalent functionalisation assisted by a poly(methyl methacrylate)-mediated transfer approach. Four types of Janus graphene are produced by co-grafting of halogen and aryl/oxygen-functional groups on each side. Chemical decorations on one side are found to be capable of affecting both chemical reactivity and physical wettability of the opposite side, indicative of communication between the two grafted groups. This novel asymmetric structure provides a platform for theoretical and experimental studies of two-dimensional chemistry and graphene devices with multiple functions.

Identifiers

PMID23385588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.